skip navigationU S P T O SealUnited States Patent and Trademark Office TTABVUE logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
TTABVUE. Trademark Trial and Appeal Board Inquiry System
v2.5.0

Summary

Query: Party Name contains all words: BRISTOL-MYERS SQUIBB
Number of results: 100+
Results are in reverse chronological order

Page #2. Previous 1 3 4 5 Next
Proceeding
Filing Date
Defendant(s),
Property(ies)
Plaintiff(s),
Property(ies)
87131702
07/13/2017
MorphoSys AG
Mark: ADIVO S#:87131702
Bristol-Myers Squibb Company
91235152
08/28/2017
Johnson & Johnson
Mark: SPRYLANA S#:87192365
Bristol-Myers Squibb Company
Mark: SPRYCEL S#:78813186 R#:3357619
Mark: SPRYCEL S#:78140234 R#:3114787
87275936
05/31/2017
United Therapeutics Corporation
Mark: ORENICELL S#:87275936
Bristol-Myers Squibb Company
87275942
05/31/2017
United Therapeutics Corporation
Mark: ORENILEFT S#:87275942
Bristol-Myers Squibb Company
87275946
05/31/2017
United Therapeutics Corporation
Mark: ORENIPLUS S#:87275946
Bristol-Myers Squibb Company
79196954
05/11/2017
DAIICHI SANKYO COMPANY, LIMITED
Mark: REKIPLA S#:79196954
Bristol-Myers Squibb & Gilead Sciences,LLC
91234057
04/18/2017
Recro Pharma, Inc.
Mark: XERIV S#:86861537
Bristol-Myers Squibb Company
Mark: ZERIT S#:74409024 R#:1909125
87189089
03/29/2017
Alkermes Pharma Ireland Limited
S#:87189089
Bristol-Myers Squibb Company
87189103
03/29/2017
Alkermes Pharma Ireland Limited
Mark: ARISTADA S#:87189103
Bristol-Myers Squibb Company
87192365
03/16/2017
JOHNSON & JOHNSON
Mark: SPRYLANA S#:87192365
Bristol-Myers Squibb Company
86861537
01/16/2017
Recro Pharma, Inc.
Mark: XERIV S#:86861537
Novartis AG
Bristol-Myers Squibb Company
91230963
11/02/2016
Hanmi Pharmaceutical Co. Ltd.
Mark: ORAXOL S#:86905851
Bristol-Myers Squibb Company
Mark: TAXOL S#:74125254 R#:1689497
91229597
08/18/2016
Aptevo Research And Development LLC (Formerly Known as Emergent Product Development Seattle, LLC,
Mark: APTEVO S#:86758041
Mark: APTEVO THERAPEUTICS S#:86768978
Mark: APTEVO BIOTHERAPEUTICS S#:86859161
Mark: APTEVO RESEARCH AND DEVELOPMENT S#:86859136
Bristol-Myers Squibb Company
Mark: OPDIVO S#:85764349 R#:4548457
Mark: OPDIVO S#:86174642 R#:4914296
86905851
07/28/2016
Hanmi Pharmaceutical Co. Ltd.
Mark: ORAXOL S#:86905851
Bristol-Myers Squibb Company
91229128
07/20/2016
Novartis AG
S#:79178554
Bristol-Myers Squibb Company
S#:86492261 R#:4794227
79178554
04/18/2016
NOVARTIS AG
S#:79178554
Bristol-Myers Squibb Company
86859161
04/11/2016
APTEVO RESEARCH AND DEVELOPMENT LLC
Mark: APTEVO BIOTHERAPEUTICS S#:86859161
Bristol-Myers Squibb Company
86859136
03/22/2016
Emergent Product Development Seattle, LL C
Mark: APTEVO RESEARCH AND DEVELOPMENT S#:86859136
Bristol-Myers Squibb Company
86768978
03/22/2016
Emergent Product Development Seattle, LL C
Mark: APTEVO THERAPEUTICS S#:86768978
Bristol-Myers Squibb Company
86758041
03/22/2016
Emergent Product Development Seattle, LL C
Mark: APTEVO S#:86758041
Bristol-Myers Squibb Company
86641987
11/06/2015
Glaxo Group Limited
Mark: STEZIPLA S#:86641987
Bristol-Myers Squibb & Gilead Sciences, LLC
86450546
10/29/2015
Bristol-Myers Squibb Company
Mark: UPL S#:86450546
AliphCom
91223736
09/09/2015
Tamer Shalaby, DDS Inc.
Mark: BRISTOL DENTAL & ORTHODONTICS S#:86401581
Bristol-Myers Squibb Company
Mark: BRISTOL-MYERS SQUIBB S#:77950600 R#:4047440
Mark: BRISTOL-MYERS SQUIBB DELIVERING HOPE HEPATITIS AWARENESS, PREVENTION AND CARE S#:77574420 R#:4164840
79163260
09/28/2015
Shionogi & Co., Ltd.
Mark: LUZIPLA S#:79163260
Bristol-Myers Squibb & Gilead Sciences, LLC
91222508
06/24/2015
Bioactives, Inc.
Mark: ELIXIS S#:86413254
Bristol-Myers Squibb Company
Mark: ELIQUIS S#:77622324 R#:3674414
Page #2. Previous 1 3 4 5 Next

Results as of 04/29/2024 11:30 AMSearch again
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY POLICY